Technical Analysis for EIGR - Eiger BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 11.51 0.70% 0.08
EIGR closed up 0.7 percent on Wednesday, May 22, 2019, on 75 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical EIGR trend table...

Date Alert Name Type % Chg
Doji - Bearish? Reversal 0.00%
Stochastic Reached Overbought Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Up 3 Days in a Row Strength 0.70%
Upper Bollinger Band Touch Strength 0.70%

Older signals for EIGR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:
Profile
Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a portfolio of late-stage drugs for orphan diseases. It offers Sarasar, which is used for the treatment of hepatitis delta; Exendin that is used for the treatment of hypoglycemia; and Bestatin, which is used for the treatment of pulmonary arterial hypertension and lymphedema. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is based in Palo Alto, California.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Pulmonary Arterial Hypertension Specialty Drugs Hepatitis Pulmonary Hypertension Orphan Diseases Hypoglycemia
Is EIGR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 20 7 Stocks To Watch For May 20, 2019
May 17 Eiger operating chief to bid adieu
May 17 Eiger BioPharmaceuticals Announces Transition of Chief Operating Officer and Executive Medical Officer
May 9 Eiger BioPharma: 1Q Earnings Snapshot
May 9 Eiger BioPharmaceuticals beats by $0.05
May 9 Eiger BioPharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
Apr 30 Eiger to Present at ChinaBio® Partnering Forum 2019
Apr 26 Do Institutions Own Shares In Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR)?
Apr 23 Weekly CFO Buys Highlight
Apr 22 54 Biggest Movers From Thursday
See more EIGR news...
Indicators
Indicator Value
52 Week High 15.33
52 Week Low 8.4
Average Volume 152,821
200-Day Moving Average 12.0036
50-Day Moving Average 12.575
20-Day Moving Average 10.9635
10-Day Moving Average 11.127
Average True Range 0.4793
ADX 20.73
+DI 19.724
-DI 16.0743
Chandelier Exit (Long, 3 ATRs ) 10.2421
Chandelier Exit (Short, 3 ATRs ) 11.8679
Upper Bollinger Band 11.5124
Lower Bollinger Band 10.4146
Percent B (%b) 1.0
BandWidth 10.013226
MACD Line -0.3258
MACD Signal Line -0.5076
MACD Histogram 0.1818
Fundamentals Value
Market Cap 96.31 Million
Num Shares 8.37 Million
EPS -5.68
Price-to-Earnings (P/E) Ratio -2.03
Price-to-Sales 0.00
Price-to-Book 4.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.34
Resistance 3 (R3) 12.30 11.99 12.20
Resistance 2 (R2) 11.99 11.78 12.01 12.15
Resistance 1 (R1) 11.75 11.65 11.87 11.79 12.11
Pivot Point 11.44 11.44 11.50 11.46 11.44
Support 1 (S1) 11.20 11.23 11.32 11.24 10.91
Support 2 (S2) 10.89 11.10 10.91 10.87
Support 3 (S3) 10.65 10.89 10.82
Support 4 (S4) 10.69